tiprankstipranks
Advertisement
Advertisement
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
PremiumCompany AnnouncementsPolyPid Earnings Call: NDA Momentum Amid Cash Strain
2M ago
PolyPid reports Q1 EPS (35c), consensus (43c)
Premium
The Fly
PolyPid reports Q1 EPS (35c), consensus (43c)
2M ago
PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired
Premium
Company Announcements
PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired
2M ago
PolyPid granted $4.3M waiver from FDA for D-Plex application
PremiumThe FlyPolyPid granted $4.3M waiver from FDA for D-Plex application
4M ago
PolyPid Earnings Call Flags Big 2026 Catalyst
Premium
Company Announcements
PolyPid Earnings Call Flags Big 2026 Catalyst
5M ago
PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
Premium
Ratings
PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
5M ago
PolyPid appoints Story as Chairman of Board of Directors
PremiumThe FlyPolyPid appoints Story as Chairman of Board of Directors
7M ago
Roth Capital healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Roth Capital healthcare analyst holds an analyst/industry conference call
7M ago
PolyPid Gains FDA Support for D-PLEX100 NDA Submission
Premium
Company Announcements
PolyPid Gains FDA Support for D-PLEX100 NDA Submission
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100